WI Harper Group’s Portfolio companies help on novel coronavirus nucleic acid testing, drug development, and medical equipment to fight the pandemic

[vc_row][vc_column][vc_column_text]WI Harper Group | 2020-03-04[/vc_column_text][/vc_column][vc_column][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1583887543634{background-color: #e5e5e5 !important;}”]We continue to see many of WI Harper Group backed companies on the front lines of the battle against coronavirus since the outbreak. For example, the electrocardiograph of Edan Instruments, the ventilators other medical equipment from Resvent Medical and Aeonmed, and the ICU System of MedicalSystem Technology have been put into use in the designated hospitals for the treatment of pneumonia. RongCloud, Ikang, Histo Medical, LinkedSee, Merit Interactive, Infinite Intelligent Pharma, and other enterprises are supporting the battle by their remote consultation, medical cloud services, big data, and AI + drug R & D. In addition, Kindstar Global, LabTech, and others in the laboratory testing of viral nucleic acid are also in contribution and support.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

| Kindstar Global was designated to conduct coronavirus nucleic acid tests

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]Kindstar Global headquarters — Wuhan Kindstar was designated by the government as the third-party medical testing laboratory in collaboration with Wuhan Huoshenshan Hospital. Meanwhile, Wuhan Kindstar was also appointed as the novel coronavirus nucleic acid testing entity by Hubei provincial Novel Coronavirus Pneumonia Prevention and Control Task Center.[/vc_column_text][vc_column_text]According to the Wuhan Municipal Health Commission’s task deployment, the patient samples collected by relevant hospitals will be transported by professionals to Kindstar headquarters in Wuhan and tested there under the biosafety compliance. Test reports will be issued to assist in the diagnosis and treatment monitoring of patients in each hospital Kindstars headquarters is the largest single laboratory building in Asia with an area of 24000 square meters.[/vc_column_text][vc_column_text]At the moment, approximately 12,000 square meters of laboratory space is available for diagnostic testing of the new coronavirus in the Kindstar laboratory building, of which 2,700 square meters has been reconstructed. The laboratory has been equipped with more than 40 large detection instruments, including 8 PCR machines. More than 300 employees have been called internally to fight the pneumonia. Kindstar is now able to perform more than 5,000 novel coronavirus tests per day, and the testing capacity will increase as the number of instruments deployed increases.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text][/vc_column_text][vc_column_text][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

| LabTech released asolution plan for the construction of novel coronavirus nucleic acid testing laboratory

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]WI Harper Group backed LabTech is an international company providing total solutions for analytical chemistry laboratories for disease control, food safety, environmental testing and material analysis. In response to the outbreak, LabTech released a solution plan for construction of novel coronavirus (COVID – 19) nucleic acid detection laboratories.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

| Resvent Medical delivered equipmentordered by Lepu Medical and Chinese Associations in United Arab Emirates

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]As a respiratory disease solution provider, Resvent Medical actively works with partners around the world to understand the resource requirements for the epidemic and does its best to meet their needs. Recently, Lepu Medical purchased a batch of high-end medical ventilators from Resvent Medical and donated all to Wuhan Wuchang Hospital and Tongji Hospital of Huazhong University of Science and Technology. A few days ago, the Overseas Chinese Association in the United Arab Emirates contacted Resvent and a total of 100 high-end dual-level ventilators were purchased from Resvent Medical and donated to the epidemic frontline.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text][/vc_column_text][vc_column_text][/vc_column_text][vc_column_text][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

| Infinite Intelligent Pharma uses AI to repurpose old drugs and to design traditional Chinese medicine prescriptions

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]Since the coronavirus outbreak, AI has become a “technology pioneer” to accelerate the development of anti-virus drugs. It’s hard to develop new drugs, so repurposing old drugs may be a viable solution. “AI may find new solutions old drugs can provide, hence greatly reduces the time spent for searching new drugs.” said Pei Jianfeng, researcher at the Center for Quantitative Biology of Academy for Advanced Interdisciplinary Studies, Peking University.[/vc_column_text][vc_column_text]Infinite Intelligent Pharma has proposed potential new applications of old drugs with the AI technology, and is working with partners to carry out research on new applications of old drugs and on the design of traditional Chinese medicine prescriptions based on the targets of virus replication and virus-host interactions.[/vc_column_text][/vc_column][vc_column][vc_column_text][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space height=”70px”][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]Translated from: https://mp.weixin.qq.com/s/eIDP1F7KecWMGFbmQRT5Mg[/vc_column_text][/vc_column][/vc_row]

WI Harper Group’s Portfolio companies help on novel coronavirus nucleic acid testing, drug development, and medical equipment to fight the pandemic

Resvent Medical is a Shenzhen, China-based medical device and solution company focused on medical respiration & ventilation field, with its core management team having spun out of Mindray’s hospitals respiratory division, with over a decade of experience in homecare devices, clinical respiratory healthcare, intelligent information system, related consumable & accessories and value added services, and capable of building a globally competitive respiratory player – i.e. the RESMED of China.